Sarcoma Alliance For Research Through Collaboration

This study is testing an immunotherapy drug called tebentafusp in people with advanced clear cell sarcoma, a rare and aggressive cancer. The trial is for patients who have a specific genetic marker (HLA-A*02:01) and whose cancer cannot be removed by surgery or has spread. Partici…

This study is testing an intravenous drug called nab-sirolimus for adults with a rare cancer called epithelioid hemangioendothelioma (EHE) that is growing or causing symptoms and needs treatment. The main goal is to see if the drug can shrink tumors. Researchers will also track h…